Atlas Trials

A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)

Clinical trial NCT02630368 · UNKNOWN

Trial details

NCT number
NCT02630368
Sponsor
Institut Bergonié
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Solid TumorsSoft-tissue SarcomaBreast Cancer
Start date
2015-09-18
Primary completion
2023-05-01
Enrollment
197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.